Democratic presidential candidate Andrew Yang Dec. 10 released his plan to lower drug costs if elected, which includes allowing Medicare to negotiate drug prices and creating public facilities to make generic drugs.
Mr. Yang's plan would also allow forced licensing of drugs if companies can't come to a reasonable agreement with the federal government on prices that match what other countries charge.
He said he would allow importation of prescription drugs from other countries "if all else fails."
According to his statement, "brand-name prescription drug prices have risen 76 percent over the past six years, and they're not slowing down."
"While drug companies complain constantly about the high cost of research, they fail to mention that almost all FDA-approved drugs over the past several years relied on research funded by the National Institute of Health," he added.
Mr. Yang also accused pharmaceutical companies of exploiting the market "and the American people."
Read the full news release here.
More articles on pharmacy:
UnitedHealth to acquire struggling specialty pharmacy
Pharmaceutical layoffs up nearly 6% from last year
Larger chunk of hospital drug spending going toward cancer treatments, study finds